I now have all the content I need. Let me compile the full student-friendly explanation.
π©Ί Thyroid & Parathyroid Surgery - Complete MBBS Guide
Compiled from Bailey & Love's Short Practice of Surgery (28th Ed) + Sabiston Textbook of Surgery
PART 1: THYROID GLAND - THE BASICS
Anatomy - Pehle Samjho Structure
The thyroid is a butterfly-shaped gland sitting anterior to the trachea at the level of C5-T1 vertebrae. It has:
- Two lobes connected by an isthmus
- A pyramidal lobe in ~50% people (leftover from embryological descent)
- Weight: ~25-30 grams in adults
Blood supply (important in surgery):
- Superior thyroid artery - from external carotid
- Inferior thyroid artery - from thyrocervical trunk of subclavian
- Ima artery - sometimes from aorta directly (important to know - can bleed badly!)
Venous drainage:
- Superior and middle thyroid veins drain into internal jugular vein
- Inferior thyroid veins drain into brachiocephalic veins
Important relations in surgery (nerve injuries happen here!):
- Recurrent laryngeal nerve (RLN) - runs in tracheoesophageal groove, controls all laryngeal muscles except cricothyroid. Injury = hoarseness (unilateral) or stridor/respiratory distress (bilateral)
- External branch of superior laryngeal nerve - runs with superior thyroid artery, controls pitch (cricket commentator's nerve - injury = loss of high-pitched voice)
- Parathyroid glands - 4 small glands sitting behind the thyroid, must be preserved!
Embryology - Where Did This Gland Come From?
Median thyroid anlage:
- Thyroid starts as a thickening of endodermal epithelium of the foregut floor (pharynx)
- It descends as the thyroglossal duct from the tongue (foramen cecum) down to its final position
- By week 5 the duct becomes solid, fragments and disappears
- Thyroid reaches final position at 7th week, starts making hormones by 10th week
Lateral thyroid anlage:
- Arises from pharyngeal endoderm, fuses with median anlage at week 5
- Contains cells from ultimobranchial bodies (4th and 5th pharyngeal pouches)
- These give rise to the parafollicular C cells (calcitonin-secreting cells) - this is super important for cancer origin!
Congenital anomalies:
- Thyroglossal duct cyst - most common - duct doesn't obliterate fully; presents as midline neck swelling that moves on swallowing AND tongue protrusion
- Treatment: Sistrunk's operation - remove cyst + middle third of hyoid bone + tract up to foramen cecum (has to go this high because duct is intimately related to hyoid)
- Lingual thyroid - gland fails to descend, stays at base of tongue
- Ectopic thyroid - anywhere along descent path
Physiology - How Does It Work?
The axis:
- Hypothalamus releases TRH β Anterior pituitary releases TSH β Thyroid releases T3 and T4
- Classic negative feedback: high T3/T4 suppresses TSH
Hormone synthesis: Iodide + Tyrosine (on thyroglobulin) β Mono/diiodotyrosine β T3/T4 (via thyroid peroxidase)
TSH levels in different states (Bailey & Love, Table 55.1):
| State | TSH | Free T4 | Free T3 |
|---|
| Euthyroid | Normal (0.3-3.3 mU/L) | Normal | Normal |
| Hyperthyroid | Low/suppressed | High | High |
| Hypothyroid (florid) | Very high | Low | Low |
| Incipient failure | High | Low-normal | Low-normal |
Thyroid-stimulating antibodies (in Graves'):
- IgG antibodies bind TSH receptors (TRAbs)
- Their action is more prolonged than TSH (16-24 hours vs 1.5-3 hours)
- Responsible for virtually ALL thyrotoxicosis cases except toxic nodules
PART 2: THYROID SWELLINGS - GOITER, NODULES & CLASSIFICATION
Goitre Classification (Bailey & Love, Table 55.3)
| Type | Subtypes |
|---|
| Simple goitre (euthyroid) | Diffuse hyperplastic (physiological, pubertal, pregnancy) / Multinodular |
| Toxic | Diffuse = Graves' disease / Multinodular toxic / Toxic adenoma |
| Neoplastic | Benign (follicular adenoma) / Malignant (see Part 3) |
| Inflammatory | Hashimoto's, De Quervain's, Riedel's |
Simple goitre causes:
- Most common worldwide: dietary iodine deficiency (endemic goitre)
- TSH overstimulation due to low circulating T3/T4
- Dyshormonogenesis (enzyme defects in hormone synthesis)
Risk of Malignancy in Thyroid Swellings - The "Rule of 12"
A solid isolated swelling in a male carries the highest risk of malignancy.
Risk factors for cancer in a nodule:
- Solid (not cystic)
- Isolated (not dominant)
- Male sex
- Young or very old age
- History of radiation exposure
- Rapid growth, hard consistency, hoarseness, dysphagia, fixity
PART 3: INVESTIGATIONS - THE WORK-UP SEQUENCE
Step-by-Step Investigation of Thyroid Swelling
1. TSH first - Always start with TFTs (thyroid function tests)
2. Ultrasound - Primary imaging for any thyroid nodule
- U1 = Normal; U2 = Benign; U3-U5 = Increasing suspicion for malignancy
- Features suggesting malignancy: microcalcification, increased vascularity, irregular margins, taller-than-wide shape, extracapsular breach, nodal involvement
- Only macroscopic capsular breach and nodal involvement are diagnostic of malignancy on US
3. FNAC (Fine Needle Aspiration Cytology) - under ultrasound guidance
- For any nodule not fully benign (not U2) on US
- Uses Thy classification system (Bailey & Love):
| Grade | Meaning |
|---|
| Thy1 | Non-diagnostic (repeat) |
| Thy1c | Non-diagnostic cystic |
| Thy2 | Non-neoplastic / Benign |
| Thy3 | Follicular (cannot distinguish adenoma vs carcinoma) |
| Thy4 | Suspicious for malignancy |
| Thy5 | Malignant |
Key FNAC limitation: FNAC can identify PTC but CANNOT distinguish follicular adenoma from follicular carcinoma - that requires histology (capsular/vascular invasion)
4. CT scan - For large goitres with tracheal compression, retrosternal extension, or when nodal metastases suspected
5. Isotope scan - Now largely abandoned except for toxic nodularity (identifies hot vs cold nodules)
6. Laryngoscopy - Pre-op assessment of RLN function (always check vocal cords before surgery!)
PART 4: THYROID CANCERS - ORIGIN AND TYPES (Most Important!)
Cell of Origin - The Master Key
This is what all MCQs will ask!
| Cancer Type | Cell of Origin | Proportion |
|---|
| Papillary (PTC) | Follicular epithelial cells | 84% |
| Follicular (FTC) | Follicular epithelial cells | 11% |
| Oncocytic/Hurthle cell (OCA) | Follicular epithelial cells | Rare |
| Poorly differentiated (PDTC) | Follicular epithelial cells | Rare |
| Anaplastic (ATC) | Follicular epithelial cells (dedifferentiated) | 1% |
| Medullary (MTC) | Parafollicular C cells | 2% |
| Primary thyroid lymphoma | B-lymphocytes | Very rare |
Remember: PTC + FTC + OCA = "Differentiated Thyroid Cancer (DTC)" because they retain ability to organify iodine (useful for radioiodine treatment)
1. Papillary Thyroid Carcinoma (PTC) - The Most Common
- Origin: Follicular epithelial cells
- Frequency: 84% of all thyroid cancers
- Demographics: Female:Male = 3:1; Peak age: 3rd-5th decade
- Spread: Via lymphatics to cervical nodes (central + lateral compartments) - this is the KEY differentiator from FTC!
- Distant mets: only 3-5% (usually lung and bone)
- Histology hallmarks:
- Complex branching papillae
- Orphan Annie eye nuclei (nuclear pseudoinclusions, nuclear clearing)
- Nuclear grooves
- Psammoma bodies (calcified concentric whorls)
- Subtypes: Follicular variant (same prognosis), Tall cell, Hobnail, Columnar (all more aggressive)
- Prognosis: Generally excellent
2. Follicular Thyroid Carcinoma (FTC) - Second Most Common
- Origin: Follicular epithelial cells
- Frequency: 11%
- Demographics: Older adults; peak 4th-6th decade; Female:Male = 3:1
- Spread: Via blood (haematogenous) to lungs and bone - this is KEY! (NOT via lymphatics like PTC)
- Regional nodal mets in <10% of cases
- Diagnosis challenge: FNAC alone CANNOT distinguish FTC from follicular adenoma. Requires histological evidence of capsular invasion and/or vascular invasion
- Prognosis: Generally good if caught early
3. Medullary Thyroid Carcinoma (MTC) - The "Different" One
- Origin: Parafollicular C cells (NOT follicular epithelium - this is what makes it unique!)
- Frequency: 2%
- Secretes: Calcitonin (tumor marker! - used for diagnosis and follow-up)
- Spread: Both lymphatic AND haematogenous
- Types:
- Sporadic: 75-80% of cases
- Familial: 20-25% - associated with MEN 2A and MEN 2B (RET proto-oncogene mutation)
- MEN associations:
- MEN 2A = MTC + Phaeochromocytoma + Primary hyperparathyroidism
- MEN 2B = MTC + Phaeochromocytoma + Marfanoid habitus + Mucosal neuromas (but no hyperparathyroidism)
- Treatment: Surgery (radioiodine does NOT work because C cells don't take up iodine)
4. Anaplastic Thyroid Carcinoma (ATC) - The Aggressive One
- Origin: Follicular epithelial cells (completely dedifferentiated - lost all normal thyroid function)
- Frequency: 1%
- Prognosis: Near 100% mortality - one of the most lethal solid tumors
- Clinical: Rapidly growing hard neck mass, invades local structures, dysphagia, stridor
- Age: Usually elderly patients (>60 years)
- Note: May arise from dedifferentiation of pre-existing PTC or FTC
Quick Summary Table - Cancer Types
| Feature | PTC | FTC | MTC | ATC |
|---|
| Frequency | 84% | 11% | 2% | 1% |
| Cell of origin | Follicular | Follicular | C cells | Follicular |
| Spread | Lymphatics | Blood | Both | Both |
| FNAC useful? | Yes | No | Yes (calcitonin) | Yes |
| Marker | Thyroglobulin | Thyroglobulin | Calcitonin + CEA | - |
| Prognosis | Excellent | Good | Moderate | Terrible |
| Radioiodine works? | Yes | Yes | No | No |
PART 5: THYROID SURGERY (THYROIDECTOMY)
Indications for Thyroidectomy
- Malignancy (confirmed or suspected - Thy4/Thy5 on FNAC)
- Compressive symptoms - Tracheal compression, dysphagia, dyspnoea
- Cosmesis - Large visible goitre
- Hyperthyroidism - Failed medical therapy, patient preference, pregnancy
- Retrosternal goitre
- Thy3 on FNAC - To get histological diagnosis (distinguish adenoma from carcinoma)
Types of Thyroid Surgery
Total thyroidectomy - Remove entire gland
- Used for: Malignancy (most cancers), bilateral toxic goitre, large multinodular goitre
Hemithyroidectomy (lobectomy) - Remove one lobe + isthmus
- Used for: Thy3 nodule (diagnostic), isolated follicular neoplasm, small low-risk PTC
Subtotal thyroidectomy - Leave a small remnant
- Used for: Graves' disease (leaving ~4-6g behind on each side to hopefully avoid permanent hypothyroidism)
- Controversy: Higher recurrence risk than total, less popular now
Near-total thyroidectomy - Like total but leaves tiny remnant to protect RLN and parathyroid
Pre-op Preparation for Thyrotoxic Patients
Before operating on a hyperthyroid patient, you MUST make them euthyroid:
Option 1: Antithyroid drugs + iodine
- Carbimazole 30-40 mg/day for 8-12 weeks until euthyroid
- Then reduce dose or use "block and replace" (continue carbimazole + add T4)
- Add iodine (Lugol's iodine) for 10 days before surgery - reduces gland vascularity and firmness
Option 2: Beta-blockers (rapid method)
- Propranolol 40-80 mg three times daily
- Controls symptoms within days (acts on target organs not the gland)
- Does NOT reduce hormone levels - must continue for 7 days post-op!
Complications of Thyroidectomy - MUST KNOW!
Immediate
- Haemorrhage (can cause airway compression - emergency!)
- Thyrotoxic storm/crisis (if patient not properly prepared)
Early
| Complication | Cause | Presentation |
|---|
| Haemorrhage | Vessel slippage | Swelling, stridor, distress |
| RLN injury | Nerve damage | Unilateral: hoarse voice; Bilateral: stridor, may need tracheostomy |
| Hypoparathyroidism | Parathyroid removal/devascularization | Hypocalcaemia = tetany, Chvostek's, Trousseau's signs |
| Superior laryngeal nerve injury | Damaged with superior thyroid artery | Loss of high-pitched voice, easy voice fatigue |
Late
- Hypothyroidism - common after total thyroidectomy, needs T4 replacement
- Recurrent hyperthyroidism - after subtotal thyroidectomy
- Keloid/hypertrophic scar
Post-op Hypocalcaemia - Important!
After total thyroidectomy, watch for calcium drop:
- Parathyroids may be accidentally removed or devascularized
- Symptoms: perioral tingling, finger tingling, carpopedal spasm, tetany
- Chvostek's sign - tap over facial nerve below zygoma β facial muscle twitch
- Trousseau's sign - inflate BP cuff above systolic for 3 min β carpal spasm
- Treatment: IV calcium gluconate acutely, long-term oral calcium + vitamin D
PART 6: PARATHYROID GLANDS - ALL BASICS
Anatomy
- 4 parathyroid glands (normally), each ~50mg weight
- Sit on posterior surface of thyroid (superior glands: more constant position; inferior glands: more variable)
- Superior glands - from 4th pharyngeal pouch
- Inferior glands - from 3rd pharyngeal pouch (migrate more, hence variable positions - can be found anywhere from mandible to mediastinum!)
- Blood supply: inferior thyroid artery predominantly
Function - Calcium Regulation
- Parathyroid hormone (PTH) - the main calcium-raising hormone
- PTH actions:
- Bone: Activates osteoclasts β bone resorption β releases calcium
- Kidney: Increases calcium reabsorption from distal tubule; Increases phosphate excretion (phosphaturia); Stimulates 1-alpha hydroxylase β more 1,25(OH)2D3 (active Vitamin D)
- Gut: Indirectly increases calcium absorption via Vitamin D
- Net result: raises serum calcium
- Regulated by: Calcium-sensing receptor (CaSR) on parathyroid cells - high Ca2+ suppresses PTH
PART 7: HYPERPARATHYROIDISM
Primary Hyperparathyroidism (PHPT) - Parathyroid's Own Problem
Cause:
- 85% - Single adenoma (one gland enlarges autonomously)
- 15% - Hyperplasia (all 4 glands enlarge)
- <1% - Parathyroid carcinoma
Pathophysiology: Disconnect in the Ca-PTH feedback - the set point at which calcium suppresses PTH is raised. So PTH stays high even when calcium is high.
Biochemistry: High Ca2+ + High/inappropriately normal PTH
Presentation - "Bones, Stones, Groans, Psychic Moans":
- Bones: Osteitis fibrosa cystica (bone pain, pathological fractures, bone cysts, brown tumors) - rare now due to early detection
- Stones: Nephrolithiasis (10% of PHPT patients have kidney stones)
- Groans: GI symptoms - nausea, constipation, peptic ulcers, pancreatitis
- Psychic Moans: Depression, anxiety, cognitive impairment, weakness
Associated syndromes: MEN1 (MEN1 gene), MEN2A (RET gene), MEN4 (CDKN1B gene), HPT-JT (CDC73 gene)
Investigation: Serum calcium (high), PTH (high), 24h urine calcium, renal ultrasound, DEXA scan, imaging for localisation (see below)
Localisation before surgery:
- Tc99m sestamibi scan - most commonly used, adenoma takes up the tracer
- Ultrasound - initial localisation
- 4D CT scan - best anatomical detail
- MRI - used when others fail
Surgery (Parathyroidectomy):
- Focused/minimally invasive parathyroidectomy for single adenoma (guided by localisation + intraoperative PTH)
- Bilateral neck exploration when unable to localise or hyperplasia suspected
- Intraoperative PTH - checked before and after resection; must fall >50% within 10 minutes to confirm successful removal (Miami criterion)
Secondary Hyperparathyroidism
- Cause: Chronic renal failure β low calcium β constant stimulus to all 4 glands β all 4 enlarge (hyperplasia)
- PTH is high but this is APPROPRIATE (reactive/compensatory)
- Treatment: Medical first (phosphate binders, calcium supplements, active Vit D, cinacalcet)
- Surgery if medical management fails
Tertiary Hyperparathyroidism
- Occurs in long-standing secondary hyperparathyroidism (usually after renal transplant)
- Glands become autonomous - now keep secreting PTH even after calcium normalises
- Essentially secondary hyperparathyroidism that has become autonomous
- Treatment: Surgical parathyroidectomy
Hypoparathyroidism
- Most commonly iatrogenic (post-thyroidectomy or parathyroidectomy)
- Low PTH β low calcium β tetany
PART 8: PARATHYROID CARCINOMA - Rare but Important
- <1% of hyperparathyroidism cases
- Very high PTH and very high calcium (often >3.5 mmol/L)
- Can be palpable in neck (unlike benign adenoma which is usually not palpable)
- Diagnosis confirmed on histology (capsular/vascular invasion)
- Treatment: En-bloc resection (wide excision)
- Risk factors: Prior neck irradiation, MEN1, HPT-JT syndrome (CDC73/HRPT2 mutation)
PART 9: MEN SYNDROMES - Quick Reference for Exams
| Syndrome | Components |
|---|
| MEN 1 (Wermer's) | Parathyroid hyperplasia + Pituitary tumors + Pancreatic tumors (3 P's) |
| MEN 2A (Sipple's) | MTC + Phaeochromocytoma + Parathyroid hyperplasia |
| MEN 2B | MTC + Phaeochromocytoma + Marfanoid habitus + Mucosal neuromas (no parathyroid disease) |
PART 10: QUICK-FIRE FACTS FOR EXAMS
| Fact | Answer |
|---|
| Most common thyroid cancer | Papillary (84%) |
| Most dangerous thyroid cancer | Anaplastic (near 100% mortality) |
| "Rule of 12" - highest risk? | Solid + isolated + male (48%) |
| FNAC cannot distinguish? | Follicular adenoma vs follicular carcinoma (need histology) |
| Marker for MTC? | Calcitonin (+ CEA) |
| RLN controls which muscles? | All intrinsic laryngeal muscles EXCEPT cricothyroid |
| External SLN injury = ? | Loss of high pitched voice |
| Post-thyroidectomy tetany cause? | Hypoparathyroidism β hypocalcaemia |
| Radioiodine not useful in? | MTC (C cells don't take up iodine), ATC |
| Sistrunk's operation = ? | Thyroglossal cyst + middle 1/3 hyoid + tract |
| Most common cause of PHPT? | Single adenoma (85%) |
| PHPT mnemonic? | Bones, Stones, Groans, Psychic Moans |
| Parathyroids from which pouch? | Superior = 4th; Inferior = 3rd |
| C cells from? | Ultimobranchial bodies (4th+5th pharyngeal pouches) |
| PTC spreads via? | Lymphatics |
| FTC spreads via? | Blood (haematogenous) |
Exam-Oriented Summary (Toh Yaad Karo!)
- Thyroid swelling moves on swallowing (attached to pretracheal fascia); thyroglossal cyst ALSO moves on tongue protrusion
- FNAC is the investigation of choice for any thyroid nodule - BUT cannot diagnose follicular carcinoma
- Graves' disease = TSH receptor stimulating antibodies (TRAbs), diffuse goitre, eye signs (exophthalmos), pretibial myxoedema
- Hashimoto's thyroiditis = anti-TPO and anti-thyroglobulin antibodies; risk of thyroid lymphoma
- Before thyroidectomy for thyrotoxicosis: make euthyroid with carbimazole, check vocal cords with laryngoscopy, monitor calcium post-op
- Intraoperative PTH falls >50% = successful parathyroid adenoma removal (Miami criterion)
- MTC is familial in 20-25% - always screen family members for RET mutation
Sources: Bailey & Love's Short Practice of Surgery 28th Ed (Ch. 55), Sabiston Textbook of Surgery (Ch. 73 & 74)